Yuandong Biotechnology won the China Patent Excellence Award
June 10, 2025
Source: drugdu
79
On June 8, Yuandong Bio(688513) announced that the company recently won the 25th China Patent Excellence Award in recognition of its invention patent for bisoprolol fumarate tablets (Sulele®) "a bisoprolol fumarate I crystal form and its preparation method". This award was sponsored by the State Intellectual Property OfficeThe Bureau and the World Intellectual Property Organization jointly organized the company's innovative drugIt is a high recognition of the efforts made in biological research and development and intellectual property protection.
This award is not expected to have a significant impact on the company's current operating performance, but it demonstrates the drug's significant advantages in terms of technological advancement, innovation and clinical value. In the future, the company will continue to strengthen its patent layout and strive to develop more high-quality innovative drugs .
In the first quarter of 2025, Yuandong Bio achieved revenue of 306 million yuan and net profit attributable to shareholders of the parent company of 60.59 million yuan.
https://finance.eastmoney.com/a/202506083424779979.html
Copyright©2025 Ddu. All rights reserved.
Read more on
- The application for the marketing approval of the innovative drug in the field of autoimmune diseases jointly developed with Connect Biopharmaceuticals has been accepted July 10, 2025
- Kanghua Biopharma terminates cooperation in tuberculosis and rabies vaccine research and development July 10, 2025
- Small nucleic acid therapy challenges GLP-1 giants July 10, 2025
- Baili Tianheng BL-B01D1 Update Progress July 10, 2025
- FDA Approves KalVista Pharmaceuticals’ Ekterly for Hereditary Angioedema July 10, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
